Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $13.82, but opened at $13.00. Ambu A/S shares last traded at $12.94, with a volume of 1,500 shares changing hands.
Ambu A/S Price Performance
The stock has a market cap of $3.25 billion, a PE ratio of 41.74 and a beta of 0.93. The business’s 50-day simple moving average is $13.63 and its 200-day simple moving average is $14.50. The company has a quick ratio of 1.63, a current ratio of 2.72 and a debt-to-equity ratio of 0.08.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a return on equity of 9.32% and a net margin of 8.86%.The company had revenue of $242.85 million for the quarter.
About Ambu A/S
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
See Also
- Five stocks we like better than Ambu A/S
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
